Abstract | BACKGROUND: MATERIALS AND METHODS: In this study, we evaluated MT-III expression in 184 patients using immunohistochemistry and in 61 cases using real-time polymerase chain reaction. RESULTS:
MT-III mRNA expression was significantly higher in NSCLC as compared to non-malignant lung tissues (NMLT; p<0.0086). MT-III expression was noted in the cytoplasm and nucleus of cancer cells. Significantly lower nuclear MT-III (p<0.0001) expression and significantly higher cytoplasmic MT-III (p=0.0068) expression was noted in the pneumocytes of NMLT, as compared to NSCLC. Nuclear MT-III expression was significantly higher in G1 cases as compared to G2 (p=0.0308) and G3 (p=0.0194) cases. Low cytoplasmic MT-III expression was associated with larger primary tumour size (p=0.0378). Lower MT-III mRNA and cytoplasmic MT-III expression was associated with poor patient outcome (p=0.0410 and p=0.0347, respectively). CONCLUSION:
MT-III expression may have an impact on the pathogenesis of NSCLC.
|
Authors | Bozena Werynska, Bartosz Pula, Beata Muszczynska-Bernhard, Agnieszka Gomulkiewicz, Aleksandra Jethon, Marzena Podhorska-Okolow, Renata Jankowska, Piotr Dziegiel |
Journal | Anticancer research
(Anticancer Res)
Vol. 33
Issue 3
Pg. 965-74
(Mar 2013)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 23482768
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Metallothionein 3
- Nerve Tissue Proteins
- RNA, Messenger
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Non-Small-Cell Lung
(etiology, metabolism, pathology)
- Cell Nucleus
(chemistry)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Lung Neoplasms
(etiology, metabolism, pathology)
- Male
- Metallothionein 3
- Middle Aged
- Nerve Tissue Proteins
(analysis, genetics, physiology)
- RNA, Messenger
(analysis)
|